Monitoring donor-derived cell-free DNA is a noninvasive means of detecting antibody-mediated rejection of a transplanted ...

A groundbreaking study has identified circulating cell-free DNA as a potential biomarker for predicting early relapse in ...

Traditional biomarkers used in kidney transplant care lack sensitivity and specificity for early detection Donor-derived cell-free DNA is used as a biomarker for detecting early graft rejection or ...

Use of a standardized cell-free (cf)DNA-sequencing and cancer-screening protocol detected cancer in nearly half of pregnant ...

Donor-derived cell-free DNA (dd-cfDNA) is a biomarker for (sub)clinical allograft injury and could be a tool for monitoring of lung allograft health across the (pre)clinical spectrum of CLAD. In this ...

At the 8-cell stage of mouse embryo development, the coordination between DNA unwinding and replication appears to improve. © ...

(UroToday.com) The 2024 Society of Urologic Oncology (SUO) annual meeting held in Dallas, between December 3 and December 6, ...

which are spurred by marks of damage in the EV-DNA to organize immune cell clusters that resist liver metastases. "This is a tumor suppressor mechanism that had not been described before ...

The National Eligibility cum Entrance Test (NEET) is a competitive medical entrance examination in India for admission to ...

▲ 点击上方蓝字关注CellPress细胞科学 ▲生命科学Life science自人类基因组计划以来，科学家不断探索疾病、健康与长寿的遗传奥秘，逐步构建起以千人基因组计划、UK Biobank、TOPMed、All of ...